Studies have found that the promoters of the AKR1B1 and RASGRF2 genes were highly methylated in breast cancer, which may serve as candidate methylation biomarkers for early breast cancer detection [28, 29]. The gene discussed is RASGRF2; the disease is breast carcinoma.